Introducing EMJ Dermatology 4.1 - European Medical Journal

Introducing EMJ Dermatology 4.1

United Kingdom, November 15, 2016: Hello and welcome to this year’s EMJ Dermatology eJournal, updating the field with cutting-edge developments within dermatological practice. Approaching the closing weeks of 2016, this issue takes a retrospective approach to bring a wide-range of peer-reviewed primary research, synopses, advice, and expertise from renowned dermatologists as well as an expansive overview of the recent 25th European Academy of Dermatology and Venereology (EADV) Congress, hosted in Vienna, Austria.

A city reflecting the unison of old and new, Vienna welcomed a record number of EADV 2016 Congress attendees; it was an excellent choice of location for the celebration of innovative achievement and the update of venerable guidelines within dermatology. With the customary framework adapted based on reviews and suggestions from the previous year, attendees were invited to shape their 5-day experience around their interests and needs, with sessions targeting experienced experts, ambitious newcomers, and those to provide a platform for discussion between the two. The renowned event also saw the return of plenary lectures, satellite symposia, role-play workshops, e-Poster presentations and ‘Aesthetic Sunday’; an opportunity for on-site training and revisions for aesthetically-led professionals. Topics spanned from geriatric skin diseases and melanoma updates, to allergy and the role of immunity within the development of cutaneous conditions.

To complement the Congress coverage, this year’s eJournal provides a selection of pre-eminent, high-quality research articles to direct the future practice of clinicians and researchers alike. Findings by Özlü and Karadağ explain the role of toll-like receptors and antimicrobial peptides in the aetiopathology of acne vulgaris, a piece selected this year as the prestigious Editor’s Pick, while its potential alleviation by diet changes and oral supplementation is discussed by Szmurło and Kucharska. Alarming presentations within dermatology clinics internationally, Pozzo-Magaña and Lazo-Langner describe the development of acute drug-reaction-induced Stevens–Johnson syndrome and toxic epidermal necrolysis, stressing the lack of reliable efficacy data from current treatment options. Kormaz and Doyuk Kartal allude to the cutaneous manifestations related to brucellosis; Nath provides an all-encompassing review of the immunopathogenesis of leprosy; and Reginatto and Silva outline common neonatal presentations of the skin. Available online now:

We sincerely hope that you find this latest edition an insightful and influential read to complement the continuous update of your clinical practice and future research ventures. Zoë Webster, Head of Publishing at EMJ, commented: “We believe that this year’s EMJ Dermatology provides a comprehensive snapshot of cutting-edge updates and imminent perplexity within the field. We continue to hope that the data and opinions expressed within our eJournal will provide a foundation for discussion and debate between all professionals.”


About the European Medical Journal
The European Medical Journal is an independent company that annually produces a collection of open-access medical eJournals covering therapeutic areas such as Respiratory, Gastroenterology, Cardiology, and Urology. By combining editorials from key opinion leaders with concise news coverage from the leading congresses within the medical industry, we aim to deliver first-class insight into ground-breaking changes and advances in medicine. The production of our high-quality, peer-reviewed eJournals, and our collaborations with independent clinical bodies result in a dynamic and contemporary tool with which to assist industry professionals across Europe in progressively developing their performance and efficacy.

Media Contact
Name: Stacey Rivers
Number: 01245 334452
E-mail: [email protected]


Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?